Article Information
History
- September 25, 2024.
Article Versions
- Version 1 (September 24, 2024 - 00:34).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Philippa Jörger1,2,
- Carina Nigg1,
- Maša Žarković1,2,
- Grit Sommer1,
- Martin Kompis3,
- Gisela Michel4,
- Marc Ansari5,6,
- Nicolas Waespe1,5,7 and
- Claudia E. Kuehni1,7,*
- 1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 2Graduate School for Health Sciences, University of Bern, Bern, Switzerland
- 3Department of ENT, Head and Neck Surgery Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland
- 4Faculty of Health Sciences and Medicine University of Lucerne, Lucerne, Switzerland
- 5CANSEARCH research platform in pediatric oncology and hematology, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland
- 6Department of Women, Child and Adolescent, Division of Pediatric Oncology and Hematology, Geneva University Hospital, University of Geneva, Geneva, Switzerland
- 7Division of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- ↵*Corresponding author
: Correspondence to: Claudia E. Kuehni, Prof. MD; Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland; Email: claudia.kuehni{at}unibe.ch; Telephone: +41 31 684 35 07
Posted September 25, 2024.
Awareness about the risk of hearing loss after ototoxic treatments in Swiss childhood cancer survivors
